Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,988 | -35,956 | 23,258 | -43,138 | -16,167 |
| Depreciation Amortization | 227 | 3,466 | 2,845 | 2,263 | 1,022 |
| Income taxes - deferred | N/A | 94 | N/A | N/A | N/A |
| Other Working Capital | 1,511 | 1,136 | -537 | 2,363 | -3,603 |
| Other Operating Activity | 1,688 | -48,214 | -94,529 | 14,374 | 2,183 |
| Operating Cash Flow | $-5,563 | $-79,473 | $-68,963 | $-24,139 | $-16,565 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -192 | 180 | -130 | -88 |
| Net Acquisitions | N/A | 138,322 | 132,363 | 17,424 | N/A |
| Purchase Sale Intangibles | -2 | -136 | -134 | -96 | -111 |
| Other Investing Activity | 51 | -1,934 | -1,825 | -149 | -92 |
| Investing Cash Flow | $47 | $136,195 | $130,718 | $17,145 | $-180 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -129 | N/A |
| Debt Repayment | -30,892 | -3,148 | -2,344 | N/A | N/A |
| Other Financing Activity | -230 | -3,574 | -3,364 | -4,866 | -1,709 |
| Financing Cash Flow | $-31,121 | $-6,722 | $-5,708 | $-4,994 | $-1,709 |
| Exchange Rate Effect | -730 | 598 | 848 | -573 | -115 |
| Beginning Cash Position | 85,664 | 35,965 | 35,808 | 36,700 | 35,600 |
| End Cash Position | 48,297 | 86,564 | 92,703 | 24,139 | 17,031 |
| Net Cash Flow | $-37,367 | $50,599 | $56,896 | $-12,561 | $-18,569 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,563 | -79,473 | -68,963 | -24,139 | -16,565 |
| Capital Expenditure | -4 | -234 | -229 | -169 | -111 |
| Free Cash Flow | -5,567 | -79,707 | -69,192 | -24,308 | -16,676 |